细胞周期蛋白依赖性激酶1活性驱动多囊肾病囊肿生长
该研究在成年发病Pkd2小鼠模型成囊前进行无偏转录组分析,发现细胞增殖是最失调通路,Cdk1为核心组分;在Pkd1模型中条件性失活Cdk1可显著改善囊性表型及肾功能,并阻断囊肿细胞增殖。
要点
- Cdk1失调是Pkd1失活所致ADPKD囊肿细胞增殖的早期驱动因素。
- 条件性失活Cdk1可改善Pkd1缺失小鼠的囊性表型和肾功能。
- 选择性靶向囊肿细胞增殖可减缓Pkd1失活引起的ADPKD进展。
核心结论
- Cdk1失调是Pkd1失活导致ADPKD囊肿细胞增殖的早期驱动因素。
- 选择性靶向囊肿细胞增殖是减缓Pkd1失活所致ADPKD进展的有效手段。
研究设计与样本
- 在成年发病Pkd2小鼠模型成囊前进行无偏转录组分析,鉴定差异表达基因。
- 以野生型和Pkd2/Ift88双敲除小鼠(受保护免于囊肿生长)作为对照。
- 通过体内研究验证候选通路在ADPKD进展中的作用。
主要发现
- RNASeq数据将细胞增殖鉴定为最失调通路,241个差异表达基因中15个与细胞周期功能相关。
- Cdk1在该分析中表现为核心组分。
- Cdk1表达在Pkd1模型ADPKD中同样失调。
- 与单独失活Pkd1相比,条件性失活Cdk1并联合Pkd1失活显著改善囊性表型和肾功能。
- Pkd1/Cdk1双敲除阻断了单独Pkd1失活所伴随的囊肿细胞增殖。
临床怎么用
- 提示Cdk1可作为ADPKD中靶向囊肿细胞增殖的潜在干预靶点。
- 支持选择性抑制囊肿细胞增殖以减缓Pkd1失活所致ADPKD进展的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mutations in PKD1 and PKD2, which encode the transmembrane proteins polycystin-1 and polycystin-2, respectively, cause autosomal dominant polycystic kidney disease (ADPKD). Polycystins are expressed in the primary cilium, and disrupting cilia structure significantly slows ADPKD progression following inactivation of polycystins. The cellular mechanisms of polycystin- and cilia-dependent cyst progression in ADPKD remain incompletely understood. METHODS: Unbiased transcriptional profiling in an adult-onset Pkd2 mouse model before cysts formed revealed significant differentially expressed genes (DEGs) in Pkd2 single-knockout kidneys, which were used to identify candidate pathways dysregulated in kidneys destined to form cysts. In vivo studies validated the role of the candidate pathway in the progression of ADPKD. Wild-type and Pkd2/Ift88 double-knockout mice that are protected from cyst growth served as controls. RESULTS: The RNASeq data identified cell proliferation as the most dysregulated pathway, with 15 of 241 DEGs related to cell cycle functions. Cdk1 appeared as a central component in this analysis. Cdk1 expression was similarly dysregulated in Pkd1 models of ADPKD, and conditional inactivation of Cdk1 with Pkd1 markedly improved the cystic phenotype and kidney function compared with inactivation of Pkd1 alone. The Pkd1/Cdk1 double knockout blocked cyst cell proliferation that otherwise accompanied Pkd1 inactivation alone. CONCLUSIONS: Dysregulation of Cdk1 is an early driver of cyst cell proliferation in ADPKD due to Pkd1 inactivation. Selective targeting of cyst cell proliferation is an effective means of slowing ADPKD progression caused by inactivation of Pkd1.
引用
- Zhang C, Balbo B, Ma M, et al. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease. J Am Soc Nephrol. 2020. PMID: 33046531. doi:10.1681/ASN.2020040511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。